|
Treatment patterns of metastatic urothelial cancer in the United States. |
|
|
Employment - Gilead Sciences; Jazz Pharmaceuticals |
Stock and Other Ownership Interests - Gilead Sciences; Jazz Pharmaceuticals |
|
|
Stock and Other Ownership Interests - Blueprint Medicines; Vertex |
|
|
No Relationships to Disclose |
|
|
Employment - Analysis Group; Komodo Health |
Stock and Other Ownership Interests - Komodo Health |
Travel, Accommodations, Expenses - Komodo Health |
|
|
Employment - Bristol-Myers Squibb/Celgene; Gilead Sciences |
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene; Gilead Sciences |
|
|
Employment - Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
Honoraria - Gilead Sciences |
Travel, Accommodations, Expenses - Gilead Sciences |
|
|
No Relationships to Disclose |
|
|
Honoraria - Clovis Oncology; Gilead Sciences; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech |
Consulting or Advisory Role - AstraZeneca; Foundation medicine; Gilead Sciences; Roche/Genentech; Seagen |
Research Funding - Astellas Pharma (Inst); EMD Serono (Inst); Foundation Medicine; Genentech; Genentech; Sanofi |
Travel, Accommodations, Expenses - Roche/Genentech |